Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric A Armstrong

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Cancer Research|August 3, 2002
Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa)Shyh-Min Huang, Jing Li, Eric A Armstrong, et al.
Cancer Research|August 4, 2004
Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitorShyhmin Huang, Eric A Armstrong, Sergio Benavente, et al.
ACS Omega|February 8, 2021
Benchmarking Quantitative Performance in Label-Free ProteomicsJames A Dowell, Logan J Wright, Eric A Armstrong, et al.
International Journal of Radiation Oncology, Biology, Physics|July 21, 2005
Angiogenesis and radiation response modulation after vascular endothelial growth factor receptor-2 (VEGFR2) blockadeJing Li, Shyhmin Huang, Eric A Armstrong, et al.
Cancer Research|November 10, 2011
p53 modulates acquired resistance to EGFR inhibitors and radiationShyhmin Huang, Sergio Benavente, Eric A Armstrong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2009
Establishment and characterization of a model of acquired resistance to epidermal growth factor receptor targeting agents in human cancer cellsSergio Benavente, Shyhmin Huang, Eric A Armstrong, et al.
Discovery Medicine|September 4, 2013
Human epidermal growth factor receptor 3 (HER3) blockade with U3-1287/AMG888 enhances the efficacy of radiation therapy in lung and head and neck carcinomaChunrong Li, Toni M Brand, Mari Iida, et al.
Molecular Cancer Therapeutics|October 17, 2013
Sym004, a novel anti-EGFR antibody mixture, augments radiation response in human lung and head and neck cancersShyhmin Huang, Chimera R Peet, Jarob Saker, et al.
Cancer Research|November 23, 2012
Dual targeting of EGFR and HER3 with MEHD7945A overcomes acquired resistance to EGFR inhibitors and radiationShyhmin Huang, Chunrong Li, Eric A Armstrong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 1, 2015
Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer model systemsZachary S Morris, Jamey P Weichert, Jarob Saker, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Cancer Research|August 3, 2002
Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa)Shyh-Min Huang, Jing Li, Eric A Armstrong, et al.
Cancer Research|August 4, 2004
Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitorShyhmin Huang, Eric A Armstrong, Sergio Benavente, et al.
ACS Omega|February 8, 2021
Benchmarking Quantitative Performance in Label-Free ProteomicsJames A Dowell, Logan J Wright, Eric A Armstrong, et al.
International Journal of Radiation Oncology, Biology, Physics|July 21, 2005
Angiogenesis and radiation response modulation after vascular endothelial growth factor receptor-2 (VEGFR2) blockadeJing Li, Shyhmin Huang, Eric A Armstrong, et al.
Cancer Research|November 10, 2011
p53 modulates acquired resistance to EGFR inhibitors and radiationShyhmin Huang, Sergio Benavente, Eric A Armstrong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2009
Establishment and characterization of a model of acquired resistance to epidermal growth factor receptor targeting agents in human cancer cellsSergio Benavente, Shyhmin Huang, Eric A Armstrong, et al.
Discovery Medicine|September 4, 2013
Human epidermal growth factor receptor 3 (HER3) blockade with U3-1287/AMG888 enhances the efficacy of radiation therapy in lung and head and neck carcinomaChunrong Li, Toni M Brand, Mari Iida, et al.
Molecular Cancer Therapeutics|October 17, 2013
Sym004, a novel anti-EGFR antibody mixture, augments radiation response in human lung and head and neck cancersShyhmin Huang, Chimera R Peet, Jarob Saker, et al.
Cancer Research|November 23, 2012
Dual targeting of EGFR and HER3 with MEHD7945A overcomes acquired resistance to EGFR inhibitors and radiationShyhmin Huang, Chunrong Li, Eric A Armstrong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 1, 2015
Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer model systemsZachary S Morris, Jamey P Weichert, Jarob Saker, et al.
Pageof 3